PRESS RELEASES
Links on this page show Action Pharma's recent press releases.
June 07, 2010
Action Pharma obtains encouraging preliminary results in a phase II clinical trial with AP214
Read more
June 03, 2010
Action Pharma completes EUR 5 million financing round to advance its lead project AP214
Read more
March 29, 2010
Action Pharma completes dosing in phase II clinical trial with AP214 to prevent acute kidney injury associated with cardiac surgery
Read more
March 24, 2010
Action Pharma focusses its strategy and appoints a new CEO
Read more
March 8, 2010
Action Pharma reports positive results in a proof of concept phase IB study in obese human volunteers treated with small molecule oral once-daily AP1030 targeted for type II diabetes associated with obesity
Read more
October 20, 2009
Action Pharma in new phase II clinical trial
Read more
February 12, 2009
Action Pharma’s CEO awarded the Novo Nordisk Prize 2009
Read more
Action Pharma recruits Torben J. Laursen to lead the commercialization of the pipeline
Read more
Action Pharma launches a phase II clinical trial with AP 214 for the treatment of organ failure associated with major cardiovascular surgery
Read more